AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Tiaprofenic acid is effective in relieving mild to moderate pain associated with various conditions, including musculoskeletal pain, rheumatoid arthritis, osteoarthritis, gout, menstrual cramps, dental pain, and postoperative pain.
Anti-inflammatory Effects: Tiaprofenic acid reduces inflammation by inhibiting the production of prostaglandins, which are substances in the body that cause pain, swelling, and inflammation. It is commonly used to reduce inflammation in conditions such as arthritis and sports injuries.
Fever Reduction: Tiaprofenic acid has antipyretic properties, meaning it can help reduce fever by acting on the hypothalamus, the part of the brain that regulates body temperature.
Musculoskeletal Conditions: Tiaprofenic acid is often prescribed for the symptomatic treatment of musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. It helps alleviate pain and stiffness associated with these conditions, improving mobility and quality of life.
Dental Pain: Tiaprofenic acid is used to manage dental pain, including toothaches, following dental procedures such as extractions or root canal treatment.
Menstrual Pain: Tiaprofenic acid can relieve menstrual pain (dysmenorrhea) by reducing uterine contractions and decreasing the production of prostaglandins, which are responsible for the uterine muscle spasms and pain associated with menstruation.
Postoperative Pain: Tiaprofenic acid may be prescribed for the management of postoperative pain following surgical procedures, providing analgesia and reducing inflammation at the site of surgery.
Adverse Effects: Like other NSAIDs, tiaprofenic acid can cause gastrointestinal side effects such as abdominal pain, indigestion, nausea, vomiting, and gastric ulcers. Long-term use or high doses of tiaprofenic acid may increase the risk of gastrointestinal bleeding and ulceration. It can also affect renal function and may cause fluid retention and hypertension in some individuals.
Cardiovascular Risk: NSAIDs, including tiaprofenic acid, have been associated with an increased risk of cardiovascular events such as heart attack and stroke, especially when used at high doses or for prolonged periods. Patients with pre-existing cardiovascular disease or risk factors should use tiaprofenic acid cautiously and under medical supervision.
Allergic Reactions: Some individuals may experience allergic reactions to tiaprofenic acid, including skin rash, itching, swelling, and respiratory symptoms such as wheezing or difficulty breathing. Serious allergic reactions such as anaphylaxis are rare but can occur.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Escherichia coli | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 0.4 | 0 | 0 |
| Allergic Rhinitis (Hay Fever) | 0.4 | 0.4 | |
| Allergies | 1 | 0.4 | 1.5 |
| Allergy to milk products | 0.8 | 0.2 | 3 |
| Alzheimer's disease | 1.2 | 1.1 | 0.09 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.9 | 0.6 | 0.5 |
| Ankylosing spondylitis | 0.6 | 0.4 | 0.5 |
| Anorexia Nervosa | 0.5 | -0.5 | |
| Antiphospholipid syndrome (APS) | 0.4 | 0.4 | |
| Asthma | 0.2 | -0.2 | |
| Atherosclerosis | 0.2 | 0.2 | |
| Atrial fibrillation | 0.5 | 0.4 | 0.25 |
| Autism | 0.7 | 1.3 | -0.86 |
| benign prostatic hyperplasia | 0.2 | 0.2 | |
| Bipolar Disorder | 0.6 | 0.2 | 2 |
| Brain Trauma | 0.2 | -0.2 | |
| Carcinoma | 0.6 | 0.4 | 0.5 |
| Celiac Disease | 0.6 | 0.4 | 0.5 |
| Cerebral Palsy | 0.4 | -0.4 | |
| Chronic Fatigue Syndrome | 0.8 | 0.2 | 3 |
| Chronic Kidney Disease | 0.4 | 0.1 | 3 |
| Chronic Lyme | 0.2 | -0.2 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.1 | -0.1 | |
| Chronic Urticaria (Hives) | 0.6 | 0.6 | 0 |
| Coagulation / Micro clot triggering bacteria | 0.6 | 0.2 | 2 |
| Colorectal Cancer | 1.6 | 0 | 0 |
| Constipation | 0.4 | 0.4 | |
| Coronary artery disease | 0.2 | 0 | 0 |
| COVID-19 | 1.2 | 1.2 | 0 |
| Crohn's Disease | 1.8 | 1.1 | 0.64 |
| cystic fibrosis | 0.6 | 0.2 | 2 |
| deep vein thrombosis | 0.6 | 0.2 | 2 |
| Depression | 1.6 | 0.7 | 1.29 |
| Eczema | 0.2 | 0.6 | -2 |
| Endometriosis | 0.8 | 0.2 | 3 |
| Epilepsy | 1 | 0.2 | 4 |
| Fibromyalgia | 0.5 | -0.5 | |
| Functional constipation / chronic idiopathic constipation | 1.6 | 0.8 | 1 |
| gallstone disease (gsd) | 0.4 | 0.4 | |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 0.6 | |
| Generalized anxiety disorder | 0.6 | 0.2 | 2 |
| Gout | 0 | 0 | |
| Graves' disease | 0.2 | 0.2 | |
| Halitosis | 0.2 | 0.2 | |
| Hashimoto's thyroiditis | 0.2 | 0.2 | 0 |
| Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.7 | 0 | 0 |
| hyperglycemia | 0.2 | 0.2 | 0 |
| hypertension (High Blood Pressure | 0.6 | 0.8 | -0.33 |
| Hypothyroidism | 0 | 0 | |
| Hypoxia | 0.2 | 0.2 | |
| IgA nephropathy (IgAN) | 0.3 | -0.3 | |
| Inflammatory Bowel Disease | 1.4 | 1.5 | -0.07 |
| Insomnia | 0.2 | 0.2 | 0 |
| Intelligence | 0.2 | 0.2 | |
| Intracranial aneurysms | 0.4 | 0.4 | |
| Irritable Bowel Syndrome | 1 | 0.5 | 1 |
| Liver Cirrhosis | 0.6 | 0.4 | 0.5 |
| Long COVID | 0.5 | 1 | -1 |
| Low bone mineral density | 0.1 | -0.1 | |
| Lung Cancer | 0.2 | 0.2 | 0 |
| ME/CFS with IBS | 0 | 0.2 | 0 |
| ME/CFS without IBS | 0.1 | 0.2 | -1 |
| Metabolic Syndrome | 1.6 | 1.2 | 0.33 |
| Mood Disorders | 1.8 | 0.7 | 1.57 |
| Multiple Sclerosis | 0.2 | 1.1 | -4.5 |
| Multiple system atrophy (MSA) | 0.2 | -0.2 | |
| Neuropathy (all types) | 0.2 | -0.2 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.4 | 0.4 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.2 | 0.5 | -1.5 |
| Obesity | 0.6 | 0.4 | 0.5 |
| obsessive-compulsive disorder | 2 | 0.2 | 9 |
| Osteoarthritis | 0.4 | 0.2 | 1 |
| Osteoporosis | 0.6 | 0.2 | 2 |
| Parkinson's Disease | 0.4 | 1 | -1.5 |
| Polycystic ovary syndrome | 0.6 | 0.4 | 0.5 |
| Postural orthostatic tachycardia syndrome | 0 | 0 | |
| primary biliary cholangitis | 0.2 | -0.2 | |
| Psoriasis | 1.2 | 0.2 | 5 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.7 | 0.8 | -0.14 |
| Rosacea | 0.2 | 0.2 | |
| Schizophrenia | 0.7 | 0.2 | 2.5 |
| scoliosis | 0 | 0.3 | 0 |
| Sjögren syndrome | 0.2 | 0.4 | -1 |
| Sleep Apnea | 0.2 | 0.2 | 0 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.4 | 0.4 | |
| Stress / posttraumatic stress disorder | 0.6 | 0.2 | 2 |
| Systemic Lupus Erythematosus | 1 | 0.2 | 4 |
| Tic Disorder | 0.2 | 0.2 | |
| Tourette syndrome | 0.2 | -0.2 | |
| Type 1 Diabetes | 1.2 | 0 | 0 |
| Type 2 Diabetes | 1.6 | 1.6 | 0 |
| Ulcerative colitis | 0.8 | 0.4 | 1 |
| Unhealthy Ageing | 0.8 | 0 | 0 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.